Remote heart protection before organ transplant
Part of Heart & circulation, Kidney & urinary, Lungs & breathing clinical trials.
This study tests whether a simple treatment performed on the donor before organ removal can help transplanted organs work better. It may help patients receiving organs from eligible brain-dead donors at a specific hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be receiving a transplanted organ (kidney, liver, pancreas-kidney, heart, or lungs)
- The donor must be a brain-dead person with a plan to harvest at least one kidney
- Your transplant surgery must be done at Helsinki University Hospital
- You must be age 18 or older
- You must sign a written consent form to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to preserve donated lungs before transplant to lower the risk of complications. It may help primary graft dysfunction, a serious lung problem after surgery.
This trial compares different care approaches for adult donors in a specific type of controlled donation after the heart stops. It aims to find which approach best supports organ/tissue use after donation.
This trial tests whether a simple “arm cuff” treatment done before a heart artery procedure can help protect the kidneys and the heart in people with congestive heart failure. If it works, it may lower the chance of kidney injury around the time of the scan/stent procedure.
This trial tests a new cooling method to safely transport donor hearts. It is for people receiving only a heart transplant (no other organs at the same time).
This trial tests a special machine that preserves donor hearts for longer periods before transplant. It may help people waiting for a heart transplant who need a heart from a donor that may be older or has some heart risks.
This trial compares two ways of preserving kidneys from donors after cardiac death before transplanting them into recipients. One method uses a machine that pumps oxygenated fluid through the kidney (called NRP), and the other uses the same method plus an additional oxygen treatment (HMPO2). The goal is to see if the extra treatment improves kidney function after transplant.
Hear when a new Transplant Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.